Gilead Sciences (GILD) Other Operating Expenses (2009 - 2026)

Gilead Sciences has reported Other Operating Expenses for 18 years, with the latest figure at $1.6 billion in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses fell 13.5% year-over-year to $1.6 billion; the trailing twelve-month figure through Mar 2026 stood at $7.6 billion (down 13.3% YoY), and the FY2025 full-year result was $7.8 billion, down 48.01% from the prior year.
• Other Operating Expenses for Q1 2026 stood at $1.6 billion, down from $2.6 billion in the prior quarter.
• The five-year high for Other Operating Expenses was $8.1 billion in Q1 2024, with the low at $1.6 billion in Q1 2026.
• Historically, Other Operating Expenses has averaged $2.5 billion across 5 years, with a median of $1.8 billion in 2025.
• Annual changes were most pronounced in 2024 — Other Operating Expenses soared 331.31% — and 2025, when it sank 77.9%.
• Gilead Sciences' Other Operating Expenses stood at $3.2 billion in 2022, then slipped by 21.53% to $2.5 billion in 2023, then sank by 36.89% to $1.6 billion in 2024, then jumped by 63.35% to $2.6 billion in 2025, then sank by 39.48% to $1.6 billion in 2026.
• The last three Other Operating Expenses figures came in at $1.6 billion (Q1 2026), $2.6 billion (Q4 2025), and $1.7 billion (Q3 2025), per Business Quant data.